Dabrafenib, Trametinib, and IMRT in Treating Patients With BRAF Mutated Anaplastic Thyroid Cancer
Conditions
- BRAF NP_004324.2:p.V600E
- BRAF V600K Mutation Present
- Thyroid Gland Anaplastic Carcinoma
Interventions
- DRUG: Dabrafenib
- RADIATION: Intensity-Modulated Radiation Therapy
- DRUG: Trametinib
Sponsor
City of Hope Medical Center
Collaborators